- Home
- DYN vs EVH Comparison
DYN vs EVH Comparison
Compare DYN & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- EVH
- Stock Information
- Founded
- DYN 1984
- EVH 2011
- Country
- DYN United States
- EVH United States
- Employees
- DYN N/A
- EVH N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- EVH Other Consumer Services
- Sector
- DYN Health Care
- EVH Consumer Discretionary
- Exchange
- DYN Nasdaq
- EVH Nasdaq
- Market Cap
- DYN 1.2B
- EVH 1.4B
- IPO Year
- DYN 2020
- EVH 2015
- Fundamental
- Price
- DYN $9.38
- EVH $10.21
- Analyst Decision
- DYN Strong Buy
- EVH Strong Buy
- Analyst Count
- DYN 15
- EVH 14
- Target Price
- DYN $43.07
- EVH $16.93
- AVG Volume (30 Days)
- DYN 3.3M
- EVH 2.7M
- Earning Date
- DYN 08-11-2025
- EVH 08-07-2025
- Dividend Yield
- DYN N/A
- EVH N/A
- EPS Growth
- DYN N/A
- EVH N/A
- EPS
- DYN N/A
- EVH N/A
- Revenue
- DYN N/A
- EVH $2,398,737,000.00
- Revenue This Year
- DYN N/A
- EVH N/A
- Revenue Next Year
- DYN N/A
- EVH $16.14
- P/E Ratio
- DYN N/A
- EVH N/A
- Revenue Growth
- DYN N/A
- EVH 10.24
- 52 Week Low
- DYN $6.36
- EVH $7.06
- 52 Week High
- DYN $47.45
- EVH $33.63
- Technical
- Relative Strength Index (RSI)
- DYN 45.89
- EVH 47.57
- Support Level
- DYN $8.95
- EVH $9.22
- Resistance Level
- DYN $9.83
- EVH $11.81
- Average True Range (ATR)
- DYN 0.55
- EVH 0.57
- MACD
- DYN 0.17
- EVH -0.27
- Stochastic Oscillator
- DYN 74.58
- EVH 34.80
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.